How is it that we can go straight to a P2 trial of RC220+AC without establishing safety and tolerability of the combo in a P1 trial first?
If I'm not mistaken the P2 trial would be seeing the first patients treated with this combo?
RAC
race oncology ltd
Add to My Watchlist
4.42%
!
$1.18

General Comments / Chat, page-13011
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.18 |
Change
0.050(4.42%) |
Mkt cap ! $200.6M |
Open | High | Low | Value | Volume |
$1.15 | $1.19 | $1.14 | $171.7K | 147.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8952 | $1.17 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.19 | 996 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8952 | 1.165 |
1 | 6470 | 1.160 |
1 | 10602 | 1.145 |
2 | 21477 | 1.140 |
4 | 15629 | 1.130 |
Price($) | Vol. | No. |
---|---|---|
1.185 | 996 | 2 |
1.190 | 6766 | 1 |
1.195 | 5334 | 2 |
1.200 | 2500 | 1 |
1.205 | 382 | 1 |
Last trade - 14.23pm 17/06/2025 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ronald Miller, Non-Executive Director
Ronald Miller
Non-Executive Director
SPONSORED BY The Market Online